Anelleo, Inc. is located in Chapel Hill, North Carolina. Current support and funding is provided by NIH-NICHD (Phase I STTR) and strategic partners (Carbon, Inc. & undisclosed pharma partnerships) to allow AnelleO to complete prototyping, preclinical studies, and IND-enabling studies.
